Digital Health Consortium

The study highlighted the need for users and healthcare providers prescribing the apps to rethink the metrics they use to judge the quality of digital health apps. #DigitalHealth #eHealth #HealthIT #MedTech #HealthTech https://lnkd.in/dcHdb5hm

Product Success: Human Factors Mastery May 30, 2024 | 5:00 PM – 6:30 PM PDT Online via Zoom Join us for a FREE InnovatorMD MasterClass: From Frustration to Innovation: Human Factors Hacks for Medical Devices. https://lnkd.in/gzRdcSMH

FDA Participates in Three New Collaborative Communities Collaborative Community Logo Recently, the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) began participating in three new collaborative communities in the medical device ecosystem: Implantable Brain-Computer Interface Collaborative Community (iBCI-CC): Aims to facilitate advances and innovation in iBCIs, to empower each user of an iBCI to lead a fuller and more independent life. OpenOximetry Collaborative Community: Seeks to improve the safety and accuracy of pulse oximeters in all populations. Smart and Autonomous Medical Systems (SaAMS) Collaborative Community: Seeks to advance the maturity, adoption, and clinical use of SaAMS to improve patient care. https://lnkd.in/gm5rw9qR

Towards Resilient Healthcare Systems! I. Healthcare Systems In modern society, healthcare systems act as pivotal pillars of community well-being and social infrastructure. They serve crucial roles not only in diagnosing and treating illness but also in preventive care, public health initiatives, and even economic stabilization II. Resilience The necessity for resilient healthcare systems has been brought into sharp focus by recent global health emergencies. There is a compelling, urgent need to prioritize and bolster healthcare systems’ resilience, paving the way for a more robust, adaptive, and effective crisis management infrastructure. III. A Framework 1. Core Resilience Development This process necessitates the meticulous management and refinement of the inherent capabilities and distinctive characteristics that have previously fortified the system amidst crisis scenarios 2. Data Collection and Management Given the dynamic nature of the healthcare system, there is an inherent necessity to amass a diverse array of data, encompassing performance indicators, the service quality, environmental factors, hazards, experiential learnings, capacities, resources 3. Situation Analysis The landscape of situational alterations is subject to continual monitoring and analysis, with the objective of discerning and scrutinizing conditions being deemed critical 4. Action Authorization Each healthcare system is obliged to make cautious decisions grounded on the unique features, imperatives, and demands it discerns amidst a crisis. These decisions, fundamentally, are organizational actions that health systems need to take to enhance their resilience and effectively manage shocks and crises 5. Evaluation The final stage entails a thorough evaluation of the authorized interventions implemented to address the identified crises, along with an assessment of their outcomes III. Outlook By advancing beyond existing crisis management models, this framework is specially tailored for a comprehensive analysis of healthcare systems. The framework aims to provide actionable strategies at every stage of this cycle, enhancing our understanding of each incident’s resolution Make sure to check out the article here: https://lnkd.in/djssCeeC #heathcare #innovation #systems #healthdata

Platform Trials emerging as new study types for evaluating Digital Health solutions A platform trial is a specific type of clinical trial designed for efficiency and adaptability, making it well-suited for evaluating rapidly evolving interventions like digital health solutions. Platform trials are not a complete replacement for clinical trials, they offer a valuable addition to the clinical research toolbox, particularly in the fast-paced and data-rich landscape of digital health. They provide a way to accelerate the development and optimisation of effective digital health solutions while ensuring their real-world effectiveness and broader applicability. Why Platform Trials are Ideal for Digital Health > Rapid Evolution: Digital health solutions change rapidly. Traditional trials can be outdated by the time they are completed. Platform trials, with their adaptive nature, can keep pace with updates and new versions of digital tools. > Multiple Interventions: In digital health, various interventions might be worth exploring (different app features, behavioural nudges, etc.). Platform trials can simultaneously test these, increasing efficiency and speed. > Real-World Data: Digital health solutions generate data in real-time. Platform trials can integrate this data for ongoing analysis, allowing quicker identification of what's working and what's not. > Patient-Centricity:  Platform trials can be designed to enroll a broader, more representative population, mirroring the real-world users of digital health apps. This can enhance the generalizability of results. Growth and M&A for Healthcare Technology companies > Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i > HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk  > HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb > HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk  #HealthTech #HealthIT #DigitalHealth #lloydgprice #NelsonAdvisors

FDA's Pioneering Approach to AI Regulation 🌐 Innovative Regulatory Frameworks: The FDA is innovating its approach to regulating AI and ML in healthcare, focusing on a lifecycle-based regulatory framework. This proactive stance is crucial for nurturing the safe integration of AI technologies in healthcare settings, ensuring they evolve without compromising patient safety. As AI continues to learn and adapt in real-world applications, such regulatory agility is pivotal for sustaining innovation while safeguarding public health. A leap forward in healthcare regulation! Discover the FDA's action plan here:https://lnkd.in/gzp4rRyA #FDA #HealthcareRegulation #AIinHealthcare #PatientSafety Forest Hill Labs: A Health Market Intelligence, Policy, and Thought Leadership Consultancy Dylan Reid(Moskowitz) The Alliance for Artificial Intelligence in Healthcare (AAIH)

We're looking forward to co-hosting a #DigitalHealth summit (Feb. 28-29) with Stanford Healthcare Innovation Lab! The event, organized by Times Higher Education, unites leaders in the field from industry, academia, government and more to discuss sector challenges and how to develop solutions at scale. Early bird pricing ends soon! Don't forget to use code STANFORD25 for a 25% discount! Register now: https://bit.ly/3vL7ijV

𝗛𝗲𝗮𝗹𝘁𝗵-𝗧𝗿𝗲𝗻𝗱𝘀 𝗽𝗿𝗼𝘂𝗱𝗹𝘆 𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝘀 𝘁𝗵𝗲 𝗳𝗶𝗿𝘀𝘁 𝗦𝘄𝗶𝘀𝘀 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗘𝘃𝗲𝗻𝘁𝘀 𝗥𝗲𝗽𝗼𝗿𝘁 The healthcare sector in Switzerland has undergone a transformative development over the last ten years, characterized by dynamism, innovation, and increased exchange. This change manifests itself not only in medical advances, but also in a flourishing event landscape. The number of events has increased dramatically in recent years. New technologies, innovative therapeutic approaches, and changing patient requirements have emphasized the need for cross-industry exchange. Swiss healthcare events are diverse and range from congresses and workshops to innovative symposia. To date, however, there has been a lack of a centralized and timely overview of the dates of these events. Health-Trends has therefore launched the Swiss Healthcare Events Report, the first report in Switzerland to provide a comprehensive overview and transparency of 47 major events in the Swiss healthcare sector for 2024. You can access the report directly via this post (see below). It is also available free of charge on our website, see here: https://lnkd.in/erEPtGYn --------------------------------------------------------- Many thanks to the team Denise Bernhart, Jonas P., and Matthias Mettler as well as to our sponsors and partners who have made this report possible: MediCongress GmbH, ELCA Group, IFAS, Swiss Healthcare Startups, ZHAW Zürcher Hochschule für Angewandte Wissenschaften, DayOne - Healthcare Innovation and digital health center bülach. #digitalhealth #innovation #healthcare --------------------------------------------------------- 👉🏻 Follow Health-Trends for more digital health updates.

Last year the World Health Organization released their World #MentalHealth report which highlighted mental health disorders as the leading cause of ‘years lived with disability’ (YLDs) across all disorders. With a staggering one billion people (more than one in eight adults and adolescents) worldwide with a mental disorder, the disease burden is enormous with high economic costs. In fact, most mental health services across the globe fail to meet the mental health needs of their populations.   Silicon Valley Bank along with Mount Sinai Innovation Partners is hosting the Emerging Innovations in Healthcare (EIH), a hybrid conference series to spotlight emerging mental health companies, so we can enable the development of better mental healthcare. Please join us and founders in the field, who will pitch to a panel of industry leaders, investors and KOLs in the heart of NYC. Event Date: Feb 15th, 3pm ET Registration Link: https://lnkd.in/e7WFREKR Mount Sinai Health System First Citizens Bank Fox Rothschild Curio Digital Therapeutics Inc. CLINICOM The Zone SonnyLife Libbie Health Inc. Raihan Faroqui, MD Matthew R. Kittay ZOI CAPITAL Kaitlin Berube Dov Shamir, Ph.D. Shailja Dixit Colette Ellis David Mohr Michelle Durham, MD, MPH, DFAPA Steven Reddy, MSc. Ben Schor Nuzi Barkatally Rohan Siddhanti Vadim Gordin Ronald M. Razmi, MD Brian Beeler Ben Schor Bill Sideris Julie Betts Ebert HITLAB Jacques Jospitre

"WASHINGTON, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The Alliance for Pediatric Device Innovation (APDI) and Pediatric Pandemic Network (PPN) have teamed up to provide a unique opportunity for innovators of pediatric medical devices, diagnostics and digital health solutions. The organizations are inviting submissions for a pitch competition that emphasizes the development of medical countermeasures (MCMs) – innovations designed to address the unique healthcare needs of children during pandemics and other disasters. MCMs play a pivotal role in bolstering readiness and response capabilities to disasters arising from a broad spectrum of threats. Competition awardees will receive grant funding provided by the Health and Resources and Services Administration (HRSA) and comprehensive support services provided by APDI and PPN. An additional incentive is the potential for a second year of funding, based on the awardees’ progress in the first year. Organizers are particularly interested in funding research and development (R&D) initiatives focused on pioneering early-stage medical technologies tailored to tackle disasters. Such initiatives also have the potential to secure subsequent funding from other federal agencies operating within this domain." https://lnkd.in/g-bHNEM6